Clinical Trial

Bowel Preparation for Colonoscopy Among Individuals With Crohn's and Ulcerative Colitis Disease.

Recruiting Phase 4
View on ClinicalTrials.gov →
Record status
This record was last updated January 8, 2025 (before its estimated December 2025 completion). Its status may not reflect the trial's current state.
Summary
The purpose of this study is to compare how effective and how tolerable two different bowel preparation laxatives are for colonoscopy. The aim is to compare oral sulfate solution (OSS) to another laxative called 2L polyethylene glycol (PEG) solution to see which is more effective and more tolerable by individuals with IBD (Crohn's disease or Ulcerative colitis).
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2024-02-29; most recent amendment 2025-01-06.
Status change: Not Yet Recruiting → Recruiting 2025-01-06
Trial Details
NCT Number NCT06298461
Lead Sponsor University of Manitoba
Collaborators: Canadian IBD Research Consortium (CIRC)
Conditions Crohn Disease, Ulcerative Colitis
Enrollment 418 participants
Start Date 2024-07-04
Primary Completion 2025-12 (estimated)
Study Completion 2026-05 (estimated)
Updated on ClinicalTrials.gov 2025-01-08